Source: Eur Respir J 2010; 35: 1221-1227
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Perez-de-Llano L. A., Carballada F., Castro Anon O., Pizarro M., Golpe R., Baloira A., Vazquez Caruncho M., Boquete M.. Exhaled nitric oxide predicts control in patients with difficult-to-treat asthma. Eur Respir J 2010; 35: 1221-1227

Member's Comments

No comment yet.

Related content which might interest you: Stability of exhaled nitric oxide (FENO) in patients with severe, steroid-dependent asthma Source: Annual Congress 2008 - Clinical utility of exhaled nitric oxide measurement Year: 2008 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Exhaled nitric oxide and asthma control: a longitudinal study in unselected patients Source: Eur Respir J 2008; 31: 539-546 Year: 2008 The levels of exhaled nitric oxide in controlled asthmatic patients with and without rhinitis Source: International Congress 2016 – Airway biomarkers Year: 2016 Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma Source: Eur Respir J 2008; 32: 344-349 Year: 2008 Changes of exhaled nitric oxide during steroid treatment of childhood asthma Source: Eur Respir J 2002; 19: 1015-1019 Year: 2002 Exhaled nitric oxide predicts response to treatment in COPD patients with exacerbation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide (FeNO) in relation to exacerbation of childhood asthma Source: Annual Congress 2009 - FeNO and other biomarkers in childhood asthma Year: 2009 Is exhaled nitric oxide (eNO) an indipendent outcome measure in chronic stable asthma? Source: Eur Respir J 2002; 20: Suppl. 38, 196s Year: 2002 Exhaled nitric oxide and its role in monitoring asthma control in atopic children Source: Annual Congress 2010 - Quality of life, asthma control and monitoring childhood asthma Year: 2010 Exhaled nitric oxide as a predictor of exacerbations of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 307s Year: 2004 Exhaled nitric oxide in childhood asthma Source: Annual Congress 2006 - Paediatric Respiratory Research Award Year: 2006 Exhaled nitric oxide and inhaled steroids in patients with stable asthma in primary care Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Effect of montelukast added to inhaled corticosteroids on fractional exhaled nitric oxide in asthmatic children Source: Eur Respir J 2002; 20: 630-634 Year: 2002 Exhaled nitric oxide in children with severe asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012 Exhaled nitric oxide is related to asthma control but not severity Source: Eur Respir J 2004; 24: Suppl. 48, 260s Year: 2004 The effect of inhaled corticosteroid therapy on exhaled nitric oxide and exhaled hydrogen peroxide in asthma patients Source: Annual Congress 2006 - Monitoring airway inflammation – exhaled markers vs induced sputum Year: 2006 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled nitric oxide (FeNO), sputum analysis and asthma control score in children with mild to moderate asthma Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children Year: 2008